Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
| Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
|---|---|---|---|---|---|---|---|
| GOLDMAN, SACHS & CO. | 361 | Goldman Sachs Institutional Funds plc | 1534361 | 11/14/2011 | D | Indefinite | $215,180,000 |
| GOLDMAN, SACHS & CO. | 361 | Global Private Opportunities Partners III LLC | 1763741 | 01/10/2019 | D | Indefinite | $214,350,000 |
| GOLDMAN, SACHS & CO. | 361 | Energy Investment Opportunities Onshore Fund LLC | 1636429 | 03/12/2015 | D | Indefinite | $213,375,000 |
| GOLDMAN, SACHS & CO. | 361 | FREO Investor Offshore, L.P. | 1569984 | 02/22/2013 | D | Indefinite | $212,390,000 |
| GOLDMAN, SACHS & CO. | 361 | Kinesis Holdings I Ltd | 1624171 | 12/16/2014 | D | Indefinite | $210,739,404 |
| GOLDMAN, SACHS & CO. | 361 | TPG Tech Adjacencies Access LLC | 1768742 | 02/22/2019 | D | Indefinite | $206,205,000 |
| GOLDMAN, SACHS & CO. | 361 | STAR Investors LP | 1777500 | 05/24/2019 | D | Indefinite | $203,595,000 |
| GOLDMAN, SACHS & CO. | 361 | Workhorse Group Inc. | 1425287 | 10/28/2020 | D | $200,000,000 | $200,000,000 |
| GOLDMAN, SACHS & CO. | 361 | Nautilus Biotechnology, Inc. | 1808805 | 06/22/2021 | D | $200,000,000 | $200,000,000 |
| GOLDMAN, SACHS & CO. | 361 | Private Equity Managers (2020) LP | 1798654 | 01/03/2020 | D | Indefinite | $199,895,000 |